Literature DB >> 18492826

Retinoids upregulate phosphoenolpyruvate carboxykinase and glyceroneogenesis in human and rodent adipocytes.

Thomas Cadoudal1, Martine Glorian, Aurélie Massias, Françoise Fouque, Claude Forest, Chantal Benelli.   

Abstract

Glyceroneogenesis is an important metabolic pathway for fatty acid reesterification in adipose tissue, thereby reducing fatty acid release. Glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C), which is the key enzyme in this pathway, are both regulated by a series of hormones and nutrients, among which all-trans retinoic acid (all-trans RA) is a transcriptional inducer of the PEPCK-C gene (Pck1). All-trans RA binds to the retinoic acid receptor (RAR) and activates it, whereas its stereoisomer 9-cis retinoic acid (9-cis RA) is a ligand for the 9-cis RA receptor (RXR). Three RXR-binding elements [retinoic acid response element (RARE)1/PCK1, RARE2, and RARE3/PCK2] were previously located in the promoter of Pck1. Using 3T3-F442A adipocytes, we demonstrated that Pck1 expression was 10-fold more sensitive to 9-cis RA (EC(50): 10 nmol/L) than to all-trans RA. We then analyzed the respective involvement of RARE1/PCK1, RARE2, and RARE3/PCK2 in the response of Pck1 to 9-cis RA and all-trans RA in adipocytes. The response to 9-cis RA mainly involved the RARE1/PCK1 element, whereas RARE2 was mainly responsive to all-trans RA. In contrast, the full response to both RA isomers involved these 2 elements and included RARE3/PCK2 as well. Furthermore, 9-cis RA, but not all-trans RA, selectively induced PCK1 in ex-vivo-treated human adipose tissue explants, with a concomitant induction of glyceroneogenesis monitored by [1-(14)C]-pyruvate incorporation into neutral lipids. The concomitant 9-cis RA-induced reduction in fatty acid output indicates an important role for this RA stereoisomer in lipid homeostasis through stimulation of PEPCK-C and glyceroneogenesis in adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492826     DOI: 10.1093/jn/138.6.1004

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Enhanced fatty acid flux triggered by adiponectin overexpression.

Authors:  Shoba Shetty; Maria A Ramos-Roman; You-Ree Cho; Jonathan Brown; Jorge Plutzky; Eric S Muise; Jay D Horton; Philipp E Scherer; Elizabeth J Parks
Journal:  Endocrinology       Date:  2011-11-01       Impact factor: 4.736

2.  The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease.

Authors:  C J Carter
Journal:  ISRN Neurol       Date:  2011-07-12

3.  Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice.

Authors:  Thomas Nordstrøm Kjær; Kasper Thorsen; Niels Jessen; Karin Stenderup; Steen Bønløkke Pedersen
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

4.  Transcriptome Analysis Reveals that Vitamin A Metabolism in the Liver Affects Feed Efficiency in Pigs.

Authors:  Yunxia Zhao; Ye Hou; Fei Liu; An Liu; Lu Jing; Changzhi Zhao; Yu Luan; Yuanxin Miao; Shuhong Zhao; Xinyun Li
Journal:  G3 (Bethesda)       Date:  2016-11-08       Impact factor: 3.154

5.  Enhancing glucose metabolism via gluconeogenesis is therapeutic in a zebrafish model of Dravet syndrome.

Authors:  Rajeswari Banerji; Christopher Huynh; Francisco Figueroa; Matthew T Dinday; Scott C Baraban; Manisha Patel
Journal:  Brain Commun       Date:  2021-01-25

6.  Transcriptomic profiling of the telomerase transformed Mesenchymal stromal cells derived adipocytes in response to rosiglitazone.

Authors:  Moza Mohamed Al-Ali; Amir Ali Khan; Abeer Maher Fayyad; Sallam Hasan Abdallah; Muhammad Nasir Khan Khattak
Journal:  BMC Genom Data       Date:  2022-03-09

7.  Vitamin A, endocrine tissues and hormones: interplay and interactions.

Authors:  Julie Brossaud; Veronique Pallet; Jean-Benoit Corcuff
Journal:  Endocr Connect       Date:  2017-08-09       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.